The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer (original) (raw)
Journal Article
,
Institut f€r Virologie und Immunbiologie der Universität W€rzburg
Versbacher Strasse 7, D-87 W€rzburg, FRG
Search for other works by this author on:
,
Institut f€r Virologie und Immunbiologie der Universität W€rzburg
Versbacher Strasse 7, D-87 W€rzburg, FRG
Search for other works by this author on:
Institut f€r Virologie und Immunbiologie der Universität W€rzburg
Versbacher Strasse 7, D-87 W€rzburg, FRG
* To whom correspondence should be addressed
Search for other works by this author on:
Received:
01 October 1990
Revision received:
04 December 1990
Accepted:
04 December 1990
Published:
11 January 1991
Cite
Thomas Brabletz, Ilona Pietrowski, Edgar Serfling, The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer, Nucleic Acids Research, Volume 19, Issue 1, 11 January 1991, Pages 61–67, https://doi.org/10.1093/nar/19.1.61
Close
Navbar Search Filter Mobile Enter search term Search
Abstract
Like Cyclosporin A (CsA), the macrollde FK 506 is a potent immunosuppresslve that inhibits early steps of T cell activation, including the synthesis of Interleukin 2 (II-2) and numerous other lymphokines. The block of 11-2 synthesis occurs at the transcriptlonal level. At concentrations that block T cell activation, FK 506 and CsA inhibit the proto-enhancer activity of Purine boxes of the 11-2 promoter and the generation of lymphocyte-specific factors binding to the Purine boxes. Under the same conditions, the DNA binding of other 11-2 enhancer factors remains unaffected by both compounds. These results support the view that FK 506 and CsA, which both inhibit the activity of peptidylprolyl cls/trans isomerases, suppress T cell activation by a similar, if not identical mechanism.
This content is only available as a PDF.
© 1991 Oxford University Press
I agree to the terms and conditions. You must accept the terms and conditions.
Submit a comment
Name
Affiliations
Comment title
Comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.
Citations
Views
Altmetric
Metrics
Total Views 53
14 Pageviews
39 PDF Downloads
Since 2/1/2017
Month: | Total Views: |
---|---|
February 2017 | 1 |
March 2017 | 1 |
April 2017 | 1 |
August 2017 | 1 |
September 2017 | 1 |
October 2017 | 1 |
December 2017 | 5 |
January 2018 | 7 |
February 2018 | 3 |
March 2018 | 4 |
April 2018 | 6 |
September 2018 | 1 |
July 2019 | 1 |
October 2019 | 1 |
November 2019 | 1 |
September 2021 | 1 |
July 2022 | 1 |
August 2022 | 1 |
October 2022 | 1 |
March 2023 | 1 |
December 2023 | 2 |
January 2024 | 1 |
March 2024 | 1 |
June 2024 | 1 |
July 2024 | 1 |
August 2024 | 2 |
September 2024 | 3 |
October 2024 | 2 |
Citations
92 Web of Science
×
Email alerts
Citing articles via
More from Oxford Academic